-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Initiates Coverage On Ascentage Pharma Group with Buy Rating, Announces Price Target of $50

Benzinga·11/10/2025 11:32:44
Listen to the news
BTIG analyst Justin Zelin initiates coverage on Ascentage Pharma Group (NASDAQ:AAPG) with a Buy rating and announces Price Target of $50.